In Vitro Analysis of the Cytocompatibility of a Novel Porcine Aortic Patch for Vascular Reconstruction

Sven Pantermehl1, Said Alkildani2, Elisa Meyer1

  • 1Clinic and Policlinic for Dermatology and Venereology, University Medical Center Rostock, Rostock, Germany.

In Vivo (Athens, Greece)
|January 1, 2022
PubMed

Insights

A new decellularized porcine aortic vascular graft shows no structural damage and is fully biocompatible. This novel graft demonstrates superior cytocompatibility compared to traditional bovine grafts, addressing the shortage of autologous vessels for cardiovascular surgery.

Area of Science:

  • Biomaterials Science
  • Cardiovascular Surgery
  • Tissue Engineering

Background:

  • Cardiovascular diseases are a leading cause of global mortality.
  • Severe arteriosclerotic damage necessitates surgical intervention.
  • A shortage of autologous vessels limits transplantation options.

Purpose of the Study:

  • To evaluate a novel decellularized porcine aortic vascular graft.
  • To assess its histological characteristics and cytocompatibility.
  • To compare its performance against a conventional bovine graft.

Main Methods:

  • Histological examination of the decellularized porcine graft.
  • In vitro cytotoxicity analysis (DIN EN ISO 10993-5).
  • Ex vivo analysis and comparison with a bovine graft.

Main Results:

  • The purification process effectively removed xenogeneic antigens and preserved microstructure.
  • Histological analysis confirmed no structural damage.
  • Cytotoxicity assays demonstrated full cytocompatibility and superior biocompatibility compared to the bovine graft.

Conclusions:

  • The novel decellularized porcine aortic graft is structurally sound and fully biocompatible.
  • The purification process is effective in decellularization and antigen removal.
  • This graft presents a promising alternative to autologous vessels in cardiovascular surgery.
Abstract

Related Concept Videos